Not a fact anymore

A high systolic blood pressure in an older adult is a harmless and necessary consequence of aging.

What we know now

Isolated systolic hypertension is a major, treatable risk factor for stroke, heart disease, kidney disease, and death. Treatment targets must still account for frailty, adverse effects, and individual circumstances.

Why it changed

Clinicians often accepted rising systolic pressure as necessary to perfuse aging tissues and worried that treatment would be dangerous. Randomized trials in older adults showed that lowering systolic pressure substantially reduced stroke and cardiovascular events.

Status
Overturned
Category
Medicine
Accepted for
≈76 years
Accepted approximately
Early–mid-20th century
Changed approximately
1970s–1990s

Systolic blood pressure often rises with age as large arteries stiffen. Because the pattern was common, clinicians could interpret it as a normal adaptation rather than disease.

There was also a plausible physiological concern: lowering pressure too aggressively might reduce blood flow to aging organs and cause dizziness, falls, or other harm.

Randomized outcome trials changed the balance. Studies such as SHEP showed that treating isolated systolic hypertension in older adults substantially reduced stroke and major cardiovascular events.

Later trials extended the evidence into very old populations.

The lesson was that common with age does not mean harmless because of age.

Treatment still requires individual judgment. Frailty, orthostatic symptoms, kidney function, medication burden, and adverse effects matter, and an appropriate target for one older adult may be wrong for another.

The overturned claim is the broad one: elevated systolic pressure is not physiologically required or benign merely because it becomes more prevalent with aging.

Evidence

Sources and what they establish

Primary research

Current evidence

Related entries

Or go somewhere else: